⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5985940 | 0.82 | — | — | |
| SCHEMBL83373 | 0.82 | — | — | |
| SCHEMBL229845 | 0.79 | — | — | |
| SCHEMBL10992971 | 0.79 | — | — | |
| SCHEMBL83374 | 0.78 | — | — | |
| SCHEMBL56883 | 0.78 | — | — | |
| SCHEMBL5985852 | 0.78 | — | — | |
| SCHEMBL384121 | 0.78 | — | — | |
| SCHEMBL1524551 | 0.75 | — | — | |
| SCHEMBL4619606 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8609633-B2 | Core 2 GlcNAc-T inhibitors | MS THERAPEUTICS LIMITED (GB) | 2013-12-17 | — | — | US | claimed |
| US-20130087745-A1 | SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS | PRECURSOR ENERGETICS, INC. (US) | 2013-04-11 | — | — | US | claimed |
| US-20120142620-A1 | CORE 2 GLCNAC-T INHIBITORS | BTG INTERNATIONAL LIMITED (GB) | 2012-06-07 | — | — | US | claimed |
| US-20100048496-A1 | Core 2 GlcNAc-T inhibitors | BTG INTERNATIONAL LIMITED (GB) | 2010-02-25 | — | — | US | claimed |
| CN-101257909-A | Core 2 glcnac-t inhibitors | BTG INT LTD (GB) | 2008-09-03 | — | — | CN | claimed |
| EP-1919486-A2 | CORE 2 GLCNAC-T INHIBITORS | BTG INTERNATIONAL LIMITED (GB) | 2008-05-14 | — | — | EP | claimed |
| US-20070010461-A1 | Core 2 GlcNAc-T inhibitors | BTG INTERNATIONAL LIMITED (GB) | 2007-01-11 | — | — | US | claimed |
| WO-2007003948-A2 | CORE 2 GLCNAC-T INHIBITORS | BTG INTERNATIONAL LIMITED (GB) | 2007-01-11 | — | — | WO | claimed |
| US-4402948-A | HEMOSTATIC | NIPPON SHINYAKU CO., LTD. (JP) | 1983-09-06 | — | — | US | claimed |
| JP-57035598-A | — | — | None | — | — | JP | disclosed |
| JP-56113799-A | — | — | None | — | — | JP | disclosed |
| US-20240191009-A1 | POLYFUNCTIONALIZED HIGH-CIS 1,4-POLYBUTADIENE AND METHOD FOR MANUFACTURING THE SAME | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2024-06-13 | — | — | US | disclosed |
| US-20240174947-A1 | SURFACTANT COMPOSITIONS | LANKEM LTD. (GB) | 2024-05-30 | — | — | US | disclosed |
| EP-4373529-A1 | FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-4820723-A | FOR TREATMENT OF HYPERSENSITIVITY, ASTHMA, SHOCK OR CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0303478-A1 | Improvements in or relating to leukotriene antagonists | ELI LILLY AND COMPANY (US) | 1989-02-15 | — | — | EP | disclosed |
| US-4402948-A | HEMOSTATIC | NIPPON SHINYAKU CO., LTD. (JP) | 1983-09-06 | — | — | US | disclosed |
| US-4402948-A | HEMOSTATIC | NIPPON SHINYAKU CO., LTD. (JP) | 1983-09-06 | — | — | US | disclosed |
| JP-S5735598-A | STERYLGLUCOSIDE DERIVATIVE | NIPPON SHINYAKU CO LTD | 1982-02-26 | — | — | JP | disclosed |
| JP-S56113799-A | GLUCOSIDE DERIVATIVE | NIPPON SHINYAKU CO LTD | 1981-09-07 | — | — | JP | disclosed |